Literature DB >> 1763627

Lip-length and snout indices in Bell's palsy. A comparison with the House grading system.

C Jansen1, P P Devriese, F G Jennekens, H J Wijnne.   

Abstract

The lip-length (LL) and snout (S) indices provide information on peri-oral muscular function. They were determined in 18 patients suffering from Bell's palsy and compared with the results obtained by scoring according to the House grading system. A high correlation was found. LL and S indices are continuous variables, which facilitates their statistical evaluation. Results of the House scoring system are given in an ordinal scale and reflect overall facial muscular function. It is concluded that the indices and the House scoring system produce a different kind of information, but they are complementary to each other in the assessment of facial muscular function.

Entities:  

Mesh:

Year:  1991        PMID: 1763627     DOI: 10.3109/00016489109100757

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  Acupuncture for sequelae of Bell's palsy: a randomized controlled trial protocol.

Authors:  Hyo-Jung Kwon; Jong-In Kim; Myeong Soo Lee; Jun-Yong Choi; Sungkeel Kang; Jie-Yoon Chung; Young-Jin Kim; Seung-Hoon Lee; Sanghoon Lee; Dongwoo Nam; Yong-Suk Kim; Jae-Dong Lee; Do-Young Choi
Journal:  Trials       Date:  2011-03-09       Impact factor: 2.279

2.  Acupuncture for the sequelae of Bell's palsy: a randomized controlled trial.

Authors:  Hyo-Jung Kwon; Jun-Yong Choi; Myeong Soo Lee; Yong-Suk Kim; Byung-Cheul Shin; Jong-In Kim
Journal:  Trials       Date:  2015-06-03       Impact factor: 2.279

3.  Clinical efficacy and safety of thread-embedding acupuncture for treatment of the sequelae of Bell's palsy: A protocol for a patient-assessor blinded, randomized, controlled, parallel clinical trial.

Authors:  Bonhyuk Goo; Seong-Mok Jeong; Jong-Uk Kim; Yeon-Cheol Park; Byung-Kwan Seo; Yong-Hyeon Baek; Tae-Han Yook; Sang-Soo Nam
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.